Cargando…
Sclerotic marginal zone lymphoma: A case report
BACKGROUND: Marginal zone lymphoma (MZL) is an indolent non-Hodgkin B cell lymphoma with various architectural pattern including perifollicular, follicular colonization, nodular, micronodular, and diffuse patterns. A sclerotic variant has not been previously reported and represents a diagnostic pitf...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523246/ https://www.ncbi.nlm.nih.gov/pubmed/37771876 http://dx.doi.org/10.5662/wjm.v13.i4.366 |
_version_ | 1785110526140874752 |
---|---|
author | Moureiden, Zade Tashkandi, Hammad Hussaini, Mohammad Omar |
author_facet | Moureiden, Zade Tashkandi, Hammad Hussaini, Mohammad Omar |
author_sort | Moureiden, Zade |
collection | PubMed |
description | BACKGROUND: Marginal zone lymphoma (MZL) is an indolent non-Hodgkin B cell lymphoma with various architectural pattern including perifollicular, follicular colonization, nodular, micronodular, and diffuse patterns. A sclerotic variant has not been previously reported and represents a diagnostic pitfall. CASE SUMMARY: A 66-year-old male developed left upper extremity swelling. Chest computed tomography (CT) in September 2020 showed 14 cm mass in left axilla. Needle core biopsy of axillary lymph node showed sclerotic tissue with atypical B lymphoid infiltrate but was non-diagnostic. Excisional biopsy was performed for diagnosis and showed extensive fibrosis and minor component of infiltrating B cells. Flow cytometry showed a small population of CD5-, CD10-, kappa restricted B cells. Monoclonal immunoglobulin heavy chain and light chain gene rearrangement were identified. Upon being diagnosed with MZL, patient was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and achieved complete remission by positron emission tomography/CT. CONCLUSION: This is an important case report because by morphology this case could have easily been overlooked as non-specific fibrosis with chronic inflammation representing a significant diagnostic pitfall. Moreover, this constitutes a new architectural pattern. While sclerotic lymphomas have rarely been described (often misdiagnosed as retroperitoneal fibrosis), we do not know of any cases describing this architectural presentation of MZL. |
format | Online Article Text |
id | pubmed-10523246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-105232462023-09-28 Sclerotic marginal zone lymphoma: A case report Moureiden, Zade Tashkandi, Hammad Hussaini, Mohammad Omar World J Methodol Case Report BACKGROUND: Marginal zone lymphoma (MZL) is an indolent non-Hodgkin B cell lymphoma with various architectural pattern including perifollicular, follicular colonization, nodular, micronodular, and diffuse patterns. A sclerotic variant has not been previously reported and represents a diagnostic pitfall. CASE SUMMARY: A 66-year-old male developed left upper extremity swelling. Chest computed tomography (CT) in September 2020 showed 14 cm mass in left axilla. Needle core biopsy of axillary lymph node showed sclerotic tissue with atypical B lymphoid infiltrate but was non-diagnostic. Excisional biopsy was performed for diagnosis and showed extensive fibrosis and minor component of infiltrating B cells. Flow cytometry showed a small population of CD5-, CD10-, kappa restricted B cells. Monoclonal immunoglobulin heavy chain and light chain gene rearrangement were identified. Upon being diagnosed with MZL, patient was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and achieved complete remission by positron emission tomography/CT. CONCLUSION: This is an important case report because by morphology this case could have easily been overlooked as non-specific fibrosis with chronic inflammation representing a significant diagnostic pitfall. Moreover, this constitutes a new architectural pattern. While sclerotic lymphomas have rarely been described (often misdiagnosed as retroperitoneal fibrosis), we do not know of any cases describing this architectural presentation of MZL. Baishideng Publishing Group Inc 2023-09-20 /pmc/articles/PMC10523246/ /pubmed/37771876 http://dx.doi.org/10.5662/wjm.v13.i4.366 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Case Report Moureiden, Zade Tashkandi, Hammad Hussaini, Mohammad Omar Sclerotic marginal zone lymphoma: A case report |
title | Sclerotic marginal zone lymphoma: A case report |
title_full | Sclerotic marginal zone lymphoma: A case report |
title_fullStr | Sclerotic marginal zone lymphoma: A case report |
title_full_unstemmed | Sclerotic marginal zone lymphoma: A case report |
title_short | Sclerotic marginal zone lymphoma: A case report |
title_sort | sclerotic marginal zone lymphoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523246/ https://www.ncbi.nlm.nih.gov/pubmed/37771876 http://dx.doi.org/10.5662/wjm.v13.i4.366 |
work_keys_str_mv | AT moureidenzade scleroticmarginalzonelymphomaacasereport AT tashkandihammad scleroticmarginalzonelymphomaacasereport AT hussainimohammadomar scleroticmarginalzonelymphomaacasereport |